Here, we publish important new scientific research and materials, discuss significant NGP category developments in the media, report on scientific conferences we’ve attended, and more. Please note not all of this content is available in certain territories.
Having taken part in the Global Forum on Nicotine panel ‘Tobacco harm reduction: the next decade’, Group Science and Regulatory Affairs Director Joe Thompson shares his further thoughts.
18 Jul 2023
We conducted a clinical trial with adult smoker volunteers to better understand the tobacco harm reduction potential of our heated tobacco system, Pulze & iD.
15 Jun 2023
In this series, we speak to Imperial scientists working in specific areas of our Scientific Assessment Framework, or SAF.
13 Jun 2023
In this series, we speak to Imperial scientists working in specific areas of our Scientific Assessment Framework, or SAF.
22 May 2023
New research suggests reduced levels of toxicants in our blu vapes are reflected in substantially reduced biological responses compared to cigarette smoke, in-vitro.
11 May 2023
In this series, we speak to Imperial scientists working in specific areas of our Scientific Assessment Framework, or SAF.
17 Apr 2023
